Novo Joins Challenge To HHS Pharma Discount Opinion
Danish drugmaker Novo Nordisk Inc. on Friday joined a slew of other pharmaceutical companies challenging the U.S. Department of Health and Human Services' view that drugmakers must give discounts to pharmacies...To view the full article, register now.
Already a subscriber? Click here to view full article